Stroke has continued to remain a leading cause of morbidity and mortality in low-income and middle-income countries. A case control study in 32 countries has identified hypertension, physical activity, apo-b/apoA1 ratio, diet, waist-to-hip ratio, psychological factors, smoking, cardiac causes, alcohol consumption, and diabetes collectively being responsible for 90.7 of attributable risks for all strokes worldwide.
Dr. Waksman and Dr. Simonton (Abbott Vascular – CMO) discussing the commercialization of bioresorbable stents (BRS) in the US. Investigator/clinician and industry leadership perspective.
The effect of omega-3 fatty acids in modifying cardiac structures following MI has not been addressed. A randomized study of 358 patients presenting with a MI has indicated that high-dose omega-3 fatty acids lead to reduction in LV systolic volume index, reductions in serum biomarkers of systemic inflammation and myocardial fibrosis.
The cardiovascular outcome of the glucagon-like peptide 1 analogue, liraglutide, as a combination therapy in type II diabetes has not been studied. A double-blind randomized study of type II diabetic and high cardiovascular risk patients has indicated that liraglutide is associated with a lower rate of the first occurrence of death from cardiovascular causes, non-fatal MI or non-fatal stroke.
Post-TAVR aortic regurgitation may occur in 10-20% and may be associated with adverse clinical outcomes. Measurement of two novel biomarkers, high molecular-weight multimers of von Willebrand factor and closure time adenine diphosphate have been shown predict the presence of post-TAVR aortic regurgitation and higher 1-year mortality.
Nicole Lou Reporter, MedPage Today/CRTonline.org
by Nicole Lou Reporter, MedPage Today/CRTonline.org
Connolly, et al.; NEJM 2016 Online
D Kalladka, et al. ; The Lancet 2016; 388:787-796
P Hess, et al.; Circ 2016; 134:517-526
What is your first line of therapy for restenosis of DES?
Drug Coated Balloon
Another Drug Eluting Stent
CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.